1 Global Catheters and Cannulas Market Insight Analysis
The global Catheters and Cannulas market is valued at USD 39,723 million in 2024, with a CAGR of 5.33% from 2024 to 2033.
Catheters are thin, flexible tubes that carry fluids into and out of a person’s body. When a patient comes into the hospital, a catheter is sometimes inserted to ensure that any necessary intravenous drugs, blood products, or fluids can be given quickly, and is also used to pass through the urethra into the bladder to drain urine. Cannulas are tubes that are inserted into the body to drain fluids or introduce medications. They can be placed in a nasal cannula to get oxygen or in an IV cannula to draw fluids or give medicines. Catheters and cannulas are an essential part of modern medicine.
Figure Global Catheters and Cannulas Market Size (M USD) and CAGR (2024-2033)
2 Catheters and Cannulas Market Growth Drivers and Restraints
Downstream demand growth: Global aging is intensifying, the number of elderly patients is increasing, and the prevalence of chronic diseases such as cardiovascular, urinary and neurological diseases is rising, which has led to an increase in hospitalization rates and a continued rise in demand for catheters and cannulas. For example, patients with end-stage renal disease require dialysis catheters for treatment, which has driven market demand growth.
In addition, people’s sedentary habits in modern life lead to the prevalence of diabetes, cardiovascular diseases, etc., and these patients often need to use medical catheters and cannulas during treatment. At the same time, the increase in the number of surgical operations, especially the widespread use of minimally invasive surgeries, has driven the demand for minimally invasive medical catheters and promoted market growth due to its advantages of less trauma and faster recovery.
Economic and medical insurance system development: With the economic development of various countries, the per capita annual income of resident households has continued to increase, and the ability to pay has increased. More patients have the financial strength to purchase medical equipment for disease treatment and management.
At the same time, the medical security system has been gradually improved, and the number of people covered by medical insurance has increased, which has provided guarantees for residents’ medical services, promoted the development of the medical industry, and in turn driven the growth of demand in the catheter and cannula market. Taking China as an example, the number of participants in basic medical insurance reached 1.35 billion in 2018, basically achieving universal medical insurance, which promoted the development of related medical equipment and consumables markets.
Technological progress: With the continuous development of biomedical material technology, clinical medical technology, surface coating technology, and minimally invasive and non-invasive technology, the demand for high-quality catheters and cannulas is increasing. For example, as a high-tech product, precision medical catheters have the characteristics of small size, complex shape, multiple cavities and variable diameters. They are widely used in minimally invasive treatment fields such as cardiovascular, cerebrovascular, urogenital diseases and tumors, which has promoted the market to high-end development. At the same time, the application of automated production technology has improved production efficiency and product standardization, which helps to reduce costs and further promote market growth.
Fierce market competition: The catheter and cannula market is highly competitive and the industry concentration is high. Although a few large companies occupy a large market share, many small and medium-sized enterprises are also pouring in, and the competitive pressure is increasing. In order to compete for market share, companies may adopt strategies such as price wars, resulting in lower product prices and squeezed profit margins, thereby affecting the company’s R&D investment and market expansion capabilities, and limiting the further growth of the market.
Fluctuation of raw material prices: Plastics, silicone, etc. are the main raw materials for the production of catheters and cannulas, and their prices are greatly affected by factors such as crude oil and natural gas. Fluctuations in raw material prices will increase the production costs of enterprises. If enterprises cannot effectively transfer costs, it will affect profitability, which will in turn have an adverse impact on market growth. For example, fluctuations in crude oil prices will directly affect the price of plastic materials, bringing uncertainty to the production and operation of enterprises.
Shortage of professional talents: In some regions, such as India, there is a shortage of nephrologists and cardiac surgeons, which limits the scale of treatment of related diseases and thus affects the demand for catheters and cannulas. The lack of professional talents has led to the inability to effectively carry out some medical services, making it difficult to fully release the market growth potential.
Policy and regulatory restrictions: The medical device industry is strictly regulated by governments of various countries, and products need to go through complex approval procedures to enter the market, such as US FDA registration and EU CE certification. This not only increases the R&D and production costs of enterprises and prolongs the time to market, but also may exclude some small and medium-sized enterprises from the market due to their inability to meet strict regulatory requirements, limiting the market’s competitive vitality and overall development speed.
3 Technological Innovations in the Catheters and Cannulas Market
Innovation in raw material formula: The company actively develops special formulas in silicone and medical-grade plastic materials. These special formulas are applied to the catheters and balloons of the products, which can improve the biocompatibility and physical properties of the products and better meet the strict clinical requirements for the products, such as improving the durability and flexibility of the products, making the catheters and cannulas safer and more reliable during use.
Innovation in production technology: In order to adapt to the materials and functional characteristics of different products, the company has independently developed various non-standard equipment and devices, covering key process technologies such as catheter molding, balloon molding, catheter tip processing and molding, and catheter surface treatment. The advanced automated production line is equipped with a precise control system, which not only ensures the stability of product quality, but also greatly improves production efficiency. For example, the automatic control of key process parameters of the catheter production line and the co-production of various types of catheters have effectively improved the company’s production capacity and product quality consistency.
Product design optimization: Focus on the ergonomic design of the product to improve the comfort of the user. For example, some catheter products fully consider the patient’s experience in design, so that the product can meet the medical function while minimizing the patient’s discomfort and improving the patient’s compliance, which is of great significance for the market promotion and long-term application of the product.
ICU Medical acquires Smiths Medical: ICU Medical completed the acquisition of Smiths Medical, integrating the two companies’ businesses in infusion, vascular access, and critical care products. The acquisition aims to expand ICU Medical’s infusion therapy product line and enable it to enter newer clinical care markets. The combined company is expected to become a leading company in the field of infusion therapy, with estimated combined revenues of approximately $2.5 billion, enhancing its competitiveness in the market and promoting further integration of industry resources.
B. Braun acquires Clik-FIX® catheter fixation device: B. Braun acquired the innovative Clik-FIX catheter fixation device product portfolio from Starboard Medical, further enriching its product line in the field of infusion therapy and pain management. Through this acquisition, B. Braun can use this innovative product to improve the patient experience and treatment effect in peripheral intravenous therapy, consolidate its leading position in the industry, and promote the company’s development in related market segments.
Other important mergers and acquisitions: Johnson & Johnson acquired Abiomed, expanding its layout in the field of cardiovascular innovation and advancing the standard of care for heart failure and rehabilitation treatment; and the company invested in Acotec Scientific Holdings Limited to obtain its innovative medical solutions, such as drug-coated balloons and other products, to promote the company’s development in the fields of vascular disease treatment. These mergers and acquisitions and restructuring activities have promoted resource sharing and complementary advantages among enterprises, accelerated technology integration and product innovation, and promoted the development of the industry to a higher level.
4 Global Catheters and Cannulas Market Size by Type
Cannulas, which are tubes inserted into the body to drain fluids or introduce medications, are expected to have a market size of approximately $10,864 million USD in 2024. This segment includes various types of cannulas such as nasal, venous, arterial, tracheostomy, gastrostomy, and cardiac cannulas. The diversity in types caters to a wide range of medical needs, from respiratory care to cardiac procedures. The nasal cannulas, in particular, are projected to dominate this segment due to their widespread use in oxygen therapy. The venous and arterial cannulas also contribute significantly, used frequently in surgeries and critical care units for fluid management and medication administration.
Catheters, on the other hand, are thin, flexible tubes that are used to access blood vessels, the urinary system, or other parts of the body for various diagnostic and therapeutic purposes. The market size for catheters in 2024 is estimated to be much larger, at approximately $28,859 million USD. This segment includes a variety of catheters such as Foley catheters, central venous catheters, peripheral venous catheters, urinary catheters (excluding Foley), hemodialysis catheters, cardiac catheters, neurological catheters, gastrointestinal catheters, and others. Foley catheters, used primarily for urinary drainage, and central venous catheters, used for long-term intravenous access, are expected to be major contributors to this market segment.
Table Global Catheters and Cannulas Market Size by Type in 2024
Type | Market Size (M USD) 2024 |
|---|---|
Cannulas | 10864 |
Catheters | 28859 |
5 Global Catheters and Cannulas Market Size by Application
Hospitals were the largest contributors to the market revenue. In 2024, the sales value of catheters and cannulas in hospitals amounted to 32,449 million US dollars. This dominant position can be attributed to several factors. Hospitals are the primary providers of comprehensive medical care, handling a vast array of complex medical procedures. They serve as the main treatment hubs for patients with serious illnesses and those requiring invasive procedures, such as surgeries, where catheters and cannulas are essential for tasks like intravenous access, drainage, and monitoring.
Ambulatory Surgical Centers (ASCs) also played a notable role in the market. In 2024, their sales value was 4,055 million US dollars. ASCs have been growing in popularity due to their ability to offer cost – effective and convenient surgical services on an outpatient basis. They perform a wide range of minimally invasive surgeries, which rely on catheters and cannulas for precise and less – invasive treatment delivery.
Long – term Care Facilities had a relatively smaller but still important share. In 2024, the sales value here was 1,003 million US dollars. These facilities cater to patients who require extended medical care, such as the elderly with chronic conditions or those recovering from serious illnesses. Catheters and cannulas are used for continuous medication administration, fluid management, and other long – term medical needs.
Table Global Catheters and Cannulas Market Size by Application in 2024
Application | Market Size (M USD) 2024 |
|---|---|
Hospitals | 32449 |
Ambulatory Surgical Centers | 4055 |
Long-term Care Facilities | 1003 |
Others | 2216 |
6 Global Catheters and Cannulas Market Size by Region
North America is anticipated to be the leading region in the global catheters and cannulas market in 2024, with an estimated market size of $13,893 million USD. This region’s dominance can be attributed to its advanced healthcare infrastructure, high healthcare expenditure, and a significant focus on medical research and development. The market is expected to grow steadily, reaching $17,394 million USD by 2029, indicating a strong and consistent demand for these medical devices.
Europe follows North America closely, with a projected market size of $10,979 million USD in 2024. The European market is characterized by a well-established healthcare system and a high adoption rate of advanced medical technologies. The region’s market is expected to grow to $13,807 million USD by 2029, reflecting the ongoing need for improved patient care and the integration of new technologies in medical practices.
Asia is projected to have a market size of $10,906 million USD in 2024. The region’s growth is driven by emerging economies such as China and India, where investments in healthcare infrastructure and the rising middle class are increasing the demand for medical devices. The market is expected to expand to $14,917 million USD by 2029, indicating a significant potential for growth and investment in this region.
South America is projected to have a market size of $1,603 million USD in 2024. The region’s market is influenced by factors such as economic stability and increasing healthcare spending. The market is expected to grow to $2,065 million USD by 2029, showing a positive outlook for the adoption of catheters and cannulas in healthcare practices.
The Middle East is projected to have a market size of $787 million USD in 2024. The region’s market is influenced by factors such as economic development and the need to improve healthcare services. The market is expected to grow to $1,049 million USD by 2029, indicating a steady demand for these medical devices.
Africa is projected to have a market size of $665 million USD in 2024. The region’s market is influenced by factors such as economic challenges and the need to improve healthcare infrastructure. The market is expected to grow to $909 million USD by 2029, showing potential for growth as healthcare systems improve.
Oceania is projected to have a market size of $890 million USD in 2024. The region’s market is influenced by factors such as economic development and the need to improve healthcare services. The market is expected to grow to $1,142 million USD by 2029, indicating a steady demand for catheters and cannulas.
Figure Global Catheters and Cannulas Market Size (M USD) by Region in 2024
7 Global Catheters and Cannulas Market Analysis by Major Players
Medtronic
Company Profile: Medtronic is a global leader in medical technology, services, and solutions. Founded in 1949 and headquartered in the United States, Medtronic operates worldwide, providing innovative healthcare solutions to improve patient care.
Business Overview: Medtronic offers a broad range of medical devices, including surgical instruments, respiratory monitoring systems, and medical supplies. The company is committed to advancing healthcare through research and development, focusing on areas such as cardiology, neurology, and diabetes care.
Product Offered: Medtronic’s product portfolio includes catheters and cannulas designed for various medical procedures, such as cardiovascular interventions, urology, and critical care. Their products are known for their precision, reliability, and innovation.
2023 Financial Summary: In 2023, Medtronic reported sales of $1,612 million USD for catheters and cannulas, with a gross margin of 49.73%.
BD (Becton Dickinson)
Company Profile: BD is a medical technology company that develops, manufactures, and sells a broad range of medical devices, instrument systems, and reagents. Established in 1897 and headquartered in the United States, BD serves healthcare institutions, life science researchers, and the pharmaceutical industry worldwide.
Business Overview: BD is engaged in the development of medical technology and products that improve patient outcomes and reduce the cost of healthcare. Their products are used in a variety of settings, including hospitals, laboratories, and home care.
Product Offered: BD offers a comprehensive line of catheters and cannulas, including vascular access devices, infusion systems, and critical care products. Their products are designed to enhance patient safety and improve clinical outcomes.
2023 Financial Summary: In 2023, BD reported sales of $1,154 million USD for catheters and cannulas, with a gross margin of 53.03%.
B. Braun
Company Profile: B. Braun is a global provider of healthcare products and services. Founded in 1839 and headquartered in Germany, B. Braun operates in over 50 countries, offering solutions for intensive care, surgery, and other medical fields.
Business Overview: B. Braun focuses on improving patient outcomes and enhancing the efficiency of healthcare delivery. They offer a wide range of products, including infusion therapy devices, pain management solutions, and surgical instruments.
Product Offered: B. Braun’s product portfolio includes a variety of catheters and cannulas used in critical care, surgery, and other medical procedures. Their products are known for their quality, safety, and innovation.
2023 Financial Summary: In 2023, B. Braun reported sales of $829 million USD for catheters and cannulas, with a gross margin of 53.08%.